Jiangsu HengRui Medicine Co., Ltd.: all 1,057 studies

Page 11 of 11. Open to participants first (303), then studies with results posted, then the rest; newest registration first within each.

• The Drug-drug Interaction of SHR3824 and SP2086Status unknownNCT02500485Phase 1
• Phase I Study of Pyrotinib in Patients With HER2-positive Solid TumorsStatus unknownNCT02500199Phase 1
• A Trial to Evaluate Safety and Tolerability of INCSHR01210 in Cancer PatientsCompletedNCT02492789Phase 1
• Pharmacokinetics of Imrecoxib in Subjects With Hepatic InsufficiencyStatus unknownNCT02456688Phase 1
• A Drug Drug Interaciton Study of Imrecoxib and Warfarin in Healthy VolunteersStatus unknownNCT02426060Phase 1
• A Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric CancerCompletedNCT02426034Phase 4
• First-in-Human Single Ascending Dose of SHR0302Status unknownNCT02423538Phase 1
• A Study of Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+Metastatic Breast Cancer Who Have Prior Received Anthracyclin, Taxane or TrastuzumabStatus unknownNCT02422199Phase 1/2
• Effect of a High-fat Meal on the Pharmacokinetics of Hetrombopag and Mass Balance Study in Healthy SubjectsCompletedNCT02409394Phase 1
• Efficacy and Safety of Azilsartan Compared to Olmesartan Medoxomil in Chinese Participants With Grade I or II Essential HypertensionStatus unknownNCT02407210Phase 3
• A Study Comparing Remimazolam Tosilate and Propofol for Intravenous General Anaesthesia in OperationsCompletedNCT02406872Phase 2
• A Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) PatientsStatus unknownNCT02403440Phase 1
• Safety and Efficacy Study of Famitinib in Patients With Advanced Colorectal Adenocarcinoma（FACT）CompletedNCT02390947Phase 3
• Study Evaluating Pyrotinib/Pyrotinib in Combination With Docetaxel in Patients With HER2+ Advanced Gastric CancerStatus unknownNCT02378389Phase 1
• The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Combination With Metformin in Type 2 Diabetes Mellitus PatientsStatus unknownNCT02366377Phase 1
• The PK/PD, Efficacy, Safety and Tolerability Study of SHR3824 in Type 2 Diabetes Mellitus PatientsStatus unknownNCT02366351Phase 1
• A Study of Famitinib Plus Docetaxel in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC)CompletedNCT02364362Phase 1
• The PK/PD Study of Multiple Dose of SHR3824 in Healthy VolunteersCompletedNCT02361138Phase 1
• Study Evaluating Pyrotinib in Combination With Capecitabine In Patients With HER2 Positive Metastatic Breast CancerCompletedNCT02361112Phase 1
• A Study of Famitinib in Patients With Advanced Non-squamous and Non-Small Cell Lung Cancer (NSCLC)SuspendedNCT02356991Phase 2
• The PK/PD Study of Single Dose of SHR3824 in Healthy VolunteersCompletedNCT02356224Phase 1
• The Drug-drug Interaction of SHR3824 and MetforminCompletedNCT02354027Phase 1
• Effect of a High-fat Meal on the Pharmacokinetics of SHR3824 and Mass Balance Study in Healthy SubjectsCompletedNCT02353975Phase 1
• Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of SHR3824 in Type 2 Diabetes Mellitus PatientsCompletedNCT02346175Phase 1
• A Study of Famitinib in Patients With Gastrointestinal Stromal TumorStatus unknownNCT02336724Phase 2
• Study of Apatinib as 3rd/4th Line Treatment in Patients With Advanced Non-Squamous Non-small Cell Lung Cancer Harboring Wild-type Epidermal Growth Factor Receptor (EGFR)Status unknownNCT02332512Phase 3
• Clinical Trial of Systolic Heart Failure Treatment of IvabRadine Hemisulfate Sustained-release Tablets （FIRST）Status unknownNCT02188082Phase 2/3
• A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving ChemotherapyCompletedNCT02119715Phase 2
• A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of Heart FailureStatus unknownNCT02012075Phase 3
• A Study of Famitinib in Patients With Advanced or Metastatic Gastroenteropancreatic Neuroendocrine TumorTerminatedNCT01994213Phase 2
• A Phase 4 Study of Imrecoxib in Treatment of Knee OsteoarthritisStatus unknownNCT01985165Phase 4
• Efficacy and Safety Study of SHR117887 in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT01984489Phase 2
• A Phase I Study of 8-week Continuous Treatment With Polyethylene Glycol Loxenatide in Patients With Type 2 DiabetesCompletedNCT01976858Phase 1
• A Phase Ⅰa Study of Remimazolam Tosylate in Healthy VolunteersCompletedNCT01970072Phase 1
• A Phase Ⅲ Study of Extended-Release Carvedilol Sulfate for the Treatment of HypertensionStatus unknownNCT01970059Phase 3
• A Phase III Study of SP2086 in Combination With Metformin in Patients With Type 2 DiabetesStatus unknownNCT01970046Phase 3
• Efficacy and Safety of SP2086 as Monotherapy in Patients With Type 2 DiabetesStatus unknownNCT01970033Phase 3
• A Study of the Effectiveness and Safety of SP2086 to Treat Type 2 DiabetesCompletedNCT01969357Phase 2
• Efficacy and Safety Study of SP2086 in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT01969318Phase 2
• A PK/PD Study of Polyethylene Glycol Loxenatide in Patients With Type 2 DiabetesCompletedNCT01965509Phase 2
• A Phase I Study of Polyethylene Glycol Loxenatide in Patients With Type 2 DiabetesCompletedNCT01965496Phase 1
• Study of Pyrotinib in Patients With Human Epidermalgrowth Factor Receptor 2 (HER2) Positive Advanced Breast CancerCompletedNCT01937689Phase 1
• A Phase I Study of Hetrombopag Olamine in Healthy Adult VolunteersCompletedNCT01830660Phase 1
• A Study of Famitinib in Patients With Advanced Metastatic Renal Cell CancerCompletedNCT01829841Phase 2
• A Study of Famitinib in Patients With Advanced Colorectal CancerCompletedNCT01762293Phase 2
• A Phase I Study of Famitinib Malate in Patients With Solid TumorCompletedNCT01762280Phase 1
• A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving ChemotherapyCompletedNCT01611051Phase 3
• A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy Receiving ChemotherapyStatus unknownNCT01560195Phase 3
• Dose Finding and Pharmacokinetics/Pharmacodynamics Study of Apatinib in the Treatment of Advanced Colorectal CancerCompletedNCT01531777Phase 2
• Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute HyponatremiaStatus unknownNCT01507727Phase 2/3
• A Phase II Study of Flumatinib Versus Imatinib to Treat Philadelphia Chromosome Positive Chronic Myelogenous LeukemiaStatus unknownNCT01503502Phase 2
• Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal CarcinomaCompletedNCT01462474Phase 1
• A Phase I Study of Henatinib in Patients With Advanced Solid MalignanciesTerminatedNCT01416623Phase 1
• Famitinib in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma (NPC)CompletedNCT01392235Phase 2
• Study of Cipatinib in Patients With HER2 Positive or Uncertain Advanced Breast CancerTerminatedNCT01301911Phase 1
• A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung CancerCompletedNCT01270386Phase 2
• A Study of Apatinib in Patients With Advanced Hepatocellular CarcinomaCompletedNCT01192971Phase 2

← Jiangsu HengRui Medicine Co., Ltd. overview and focus areas